The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
Top Cited Papers
Open Access
- 30 June 2009
- Vol. 338 (jun30 1) , b2376
- https://doi.org/10.1136/bmj.b2376
Abstract
F1000Prime Recommended Article: The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials.Keywords
This publication has 38 references indexed in Scilit:
- Primary Prevention of Cardiovascular Mortality and Events With Statin TreatmentsJournal of the American College of Cardiology, 2008
- Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trialsBMJ, 2008
- Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ, 2003
- Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemiaJournal of the American College of Cardiology, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factorsThe American Journal of Cardiology, 1993
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986